Qube Research & Technologies (QRT)’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
476,405
+275,082
+137% +$7.69M 0.01% 1251
2026
Q1
$7.37M Buy
201,323
+181,444
+913% +$7.16M 0.01% 1466
2025
Q4
$907K Sell
19,879
-17,621
-47% -$785K ﹤0.01% 2592
2025
Q3
$1.59M Buy
+37,500
New +$1.41M ﹤0.01% 2336
2025
Q2
Sell
-12,889
Closed -$317K 3534
2025
Q1
$317K Buy
+12,889
New +$358K ﹤0.01% 2718
2024
Q4
Sell
-21,262
Closed -$566K 3431
2024
Q3
$566K Buy
+21,262
New +$553K ﹤0.01% 2227
2024
Q2
Sell
-10,038
Closed -$212K 3770
2024
Q1
$212K Sell
10,038
-5,281
-34% -$98.3K ﹤0.01% 2997
2023
Q4
$274K Buy
15,319
+6,015
+65% +$93.5K ﹤0.01% 2630
2023
Q3
$141K Buy
+9,304
New +$151K ﹤0.01% 2542
2021
Q3
Sell
-12,131
Closed -$345K 2164
2021
Q2
$345K Sell
12,131
-3,259
-21% -$88.8K ﹤0.01% 1492
2021
Q1
$348K Buy
+15,390
New +$377K 0.01% 1379
2020
Q2
Sell
-10,352
Closed -$175K 1692
2020
Q1
$175K Buy
+10,352
New +$266K 0.01% 896

Other funds holding AORT

Qube Research & Technologies (QRT)'s AORT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Artivion (AORT) stake by 137% in Q2 2026, buying an estimated $7.69M and bringing the position to 476,405 shares worth $10.7M. The position accounts for 0.01% of the portfolio, ranked #1251.

Qube Research & Technologies (QRT) first reported a position in AORT in Q1 2020 and has held it in 12 quarters since. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 476,405 shares of Artivion worth $10.7M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 275,082 Artivion shares in Q2 2026, an estimated $7.69M.
  • Artivion made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1251 holding.
  • Qube Research & Technologies (QRT) first reported a position in Artivion in Q1 2020 and has held it in 12 quarters since.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.